Ongoing research aims to better understand the mechanisms by which BRCA mutations lead to cancer, identify new mutations and their associated risks, and develop more effective prevention and treatment strategies. Large-scale epidemiological studies and biobanks are invaluable resources in this endeavor, providing the data needed to drive advancements in the field.
